Print

New ANDA Cases

Case Name Date Filed Judge Drug Patent No(s).

Alcon Research, Ltd. v. Micro Labs Ltd., 14-0014 (D. Del.)

Jan. 9, 2014

Hon. Sue L. Robinson

Travatan Z® (travoprost ophthalmic solution)

8,268,299
8,323,630
8,388,941

Biodelivery Sciences International, Inc. v. RB Pharma. Ltd., IPR2014-00325 (PTAB)

Jan. 15, 2014

N/A

Suboxone® (buprenorphine hydrochloride / naloxone hydrochloride)

8,475,832

Amneal Pharma., LLC v. Endo Pharma., Inc., IPR2014-00360 (PTAB)

Jan. 16, 2014

N/A

Opana® ER (oxymorphone hydrochloride extended-release tablets)

8,329,216

Amneal Pharma., LLC v. Endo Pharma., Inc., IPR2014-00361 (PTAB)

Jan. 16, 2014

N/A

Opana® ER (oxymorphone hydrochloride extended-release tablets)

8,309,122

Takeda Pharma. Co., Ltd. v. Mylan Inc., 14-0314
(N.D. Cal.)

Jan. 21, 2014

Hon. Lucy H. Koh

Dexilant® (dexlansoprazole delayed-release capsules)

7,339,064

Lyne Labs., Inc. v. Lupin Ltd., 14-10153 (D. Mass.)

Jan. 21, 2014

Hon. Nathaniel M. Gorton

Phoslyra® (calcium acetate oral solution)

8,591,938
8,592,480

Lyne Labs., Inc. v. Par Pharma., Inc., 14-10154
(D. Mass.)

Jan. 21, 2014

Hon. Nathaniel M. Gorton

Phoslyra® (calcium acetate oral solution)

8,591,938
8,592,480

Millennium Pharma., Inc. v. Teva Pharma. USA, Inc., 14-0093 (D. Del.)

Jan. 22, 2014

Hon. Gregory M. Sleet

Velcade® (bortezomib injection)

6,713,446
6,958,319

Cadence Pharma., Inc. v. Wockhardt Ltd., 14-0094 (D. Del.)

Jan. 22, 2014

Hon. Leonard P. Stark

Ofirmev® (acetaminophen solution)

6,028,222
6,992,218

Eli Lilly and Co. v. Glenmark Generics Inc., USA, 14-0104 (S.D. Ind.)

Jan. 23, 2014

Hon. Tanya W. Pratt

Alimta® (pemetrexed disodium for injection)

7,772,209

Eli Lilly and Co. v. Par Pharma. Cos., Inc., 14-0109 (S.D. Ind.)

Jan. 23, 2014

Hon. Sarah E. Barker

Effient® (prasugrel hydrochloride tablets)

8,404,703
8,569,325

Cadence Pharma., Inc. v. Wockhardt Ltd., 14-0485 (D.N.J.)

Jan. 23, 2014

Hon. Renee M. Bumb

Ofirmev® (acetaminophen solution)

6,028,222
6,992,218

AbbVie Inc. v. Roxane Labs., Inc., 14-0085 (S.D. Ohio)

Jan. 23, 2014

Hon. Michael H. Watson

Norvir® (ritonavir tablets)

8,470,347

Eli Lilly and Co. v. Par Pharma. Cos., Inc., 14-0508 (D.N.J.)

Jan. 24, 2014

Hon. Claire C. Cecchi

Effient® (prasugrel hydrochloride tablets)

8,404,703
8,569,325

Alcon Research, Ltd. v. Cipla Ltd., 14-0131 (S.D. Ind.)

Jan. 29, 2014

Hon. Richard L. Young

Pataday® (olopatadine hydrochloride ophthalmic solution)

6,995,186
7,402,609

Novartis Pharma. Corp. v. Noven Pharma., Inc., 14-0111 (D. Del.)

Jan. 30, 2014

Hon. Richard G. Andrews

Exelon® Patch (rivastigmine transdermal system or extended release film)

6,316,023
6,335,031

Sanofi-Aventis U.S. LLC v. Eli Lilly and Co., 14-0113
(D. Del.)

Jan. 30, 2014

Hon. Richard G. Andrews

Lantus® / Lantus® SoloSTAR® (insulin glargine [rDNA origin] for injection)

8,556,864
8,603,044
7,476,652
7,713,930

Teijin Ltd. v. Ranbaxy Labs., Ltd., 14-0117 (D. Del.)

Jan. 31, 2014

Hon. Sue L. Robinson

Uloric® (febuxostat tablets)

6,225,474

Forest Labs., Inc. v. Teva Pharma. USA, Inc., 14-0121 (D. Del.)

Jan. 31, 2014

Hon. Leonard P. Stark

Namenda XR® (memantine hydrochloride extended-release capsules)

5,061,703
8,039,009
8,168,209
8,173,708
8,283,379
8,329,752
8,362,085
8,598,233

Cephalon, Inc. v. Actavis LLC, 14-0122 (D. Del.)

Jan. 31, 2014

Hon. Gregory M. Sleet

Treanda® (bendamustine hydrochloride)

8,445,524
8,436,190

Senju Pharma. Co., Ltd. v. Lupin, Ltd., 14-0667 (D.N.J.)

Jan. 31, 2014

Hon. Jerome B. Simandle

Prolensa® (bromfenac ophthalmic solution 0.07%)

8,129,431

Novartis Pharma. Corp. v. Dr. Reddy’s Labs., Ltd., 14-0157 (D. Del.)

Feb. 5, 2014

Hon. Leonard P. Stark

Gleevec® (imatinib mesylate capsules)

6,894,051

Forest Labs., Inc. v. Glenmark Generics Inc., 14-0159
(D. Del.)

Feb. 6, 2014

Hon. Sue L. Robinson

Savella® (milnacipran hydrochloride tablets)

6,602,911
7,888,342
7,994,220

Fresenius Kabi USA, LLC v. Dr. Reddy’s Lab., Ltd.,
14-0160 (D. Del.)

Feb. 6, 2014

Hon. Sue L. Robinson

Diprivan® (propofol injectable emulsion)

8,476,010

Fresenius Kabi USA, LLC v. Watson Labs., Inc. 14-0161 (D. Del.)

Feb. 6, 2014

Hon. Sue L. Robinson

Diprivan® (propofol injectable emulsion)

8,476,010

Novartis Pharma. Corp. v. Dr. Reddy’s Labs., Ltd., 14-0785 (D.N.J.)

Feb. 6, 2014

Hon. Claire C. Cecchi

Gleevec® (imatinib mesylate capsules)

6,894,051

Teijin Ltd. v. Hetero USA, Inc., 14-0166 (D. Del.)

Feb. 7, 2014

Hon. Sue L. Robinson

Uloric® (febuxostat tablets)

6,225,474

Teijin Ltd. v. Lupin Ltd., 14-0184 (D. Del.)

Feb. 12, 2014

Hon. Sue L. Robinson

Uloric® (febuxostat tablets)

6,225,474

Teijin Ltd. v. Roxane Labs., Inc., 14-0189 (D. Del.)

Feb. 12, 2014

Hon. Sue L. Robinson

Uloric® (febuxostat tablets)

6,225,474

Merck Sharp & Dohme Corp. v. Xellia Pharma. APS, 14-0199 (D. Del.)

Feb. 14, 2014

Hon. Richard G. Andrews

Cancidas® (caspofungin acetate injection)

5,952,300

Forest Labs., Inc. v. Apotex Corp., 14-0200 (D. Del.)

Feb. 14, 2014

Hon. Leonard P. Stark

Namenda XR® (memantine hydrochloride extended-release capsules)

8,039,009
8,168,209
8,173,708
8,283,379
8,329,752
8,362,085
8,598,233

Salix Pharma., Inc. v. Novel Labs., Inc., 14-0213 (D. Del.)

Feb. 18, 2014

Hon. Gregory M. Sleet

Apriso® (mesalamine extended-release capsules)

6,551,620
8,337,886
8,496,965

Otsuka Pharma. Co., Ltd. v. Torrent Pharma. Ltd., 14-1078 (D.N.J.)

Feb. 18, 2014

Hon. Jerome B. Simandle

Abilify® (aripiprazole tablets)

8,017,615
8,580,796

Merck Sharp & Dohme Corp. v. Xellia Pharma. APS, 14-0124 (W.D. Wis.)

Feb. 18, 2014

Hon. Stephen L. Crocker

Cancidas® (caspofungin acetate injection)

5,952,300

AbbVie Inc. v. Aurobindo Pharma Ltd., 14-0215
(D. Del.)

Feb. 19, 2014

Hon. Gregory M. Sleet

Zemplar® (paricalcitol injection)

5,597,815
6,136,799
6,361,758

Meda Pharma. Inc. v. Perrigo Israel Pharma. Ltd., 14-1241 (D.N.J.)

Feb. 25, 2014

Hon. Joel A. Pisano

Astepro® (azelastine hydrochloride nasal spray)

8,518,919

Sanofi v. Glenmark Generics Inc., USA, 14-0264 (D. Del.)

Feb. 26, 2014

Hon. Richard G. Andrews

Multaq® (dronedarone tablets)

8,318,800
8,410,167
8,602,215

Sanofi v. Watson Labs., Inc., 14-0265 (D. Del.)

Feb. 26, 2014

Hon. Richard G. Andrews

Multaq® (dronedarone tablets)

8,318,800
8,410,167
8,602,215

Takeda Pharma. USA, Inc. v. Watson Labs., Inc., 14-0268 (D. Del.)

Feb. 27, 2014

Hon. Sue L. Robinson

Colcrys® (colchicine, USP)

7,601,758
7,619,004
7,820,681
7,915,269
7,964,647
7,964,648
7,981,938
8,093,296
8,093,297
8,097,655
8,415,395
8,415,396
8,440,721
8,440,722

Lyne Labs., Inc. v. Roxane Labs., Inc., 14-10460
(D. Mass.)

Feb. 27, 2014

Hon. Nathaniel M. Gorton

Phoslyra® (calcium acetate oral solution)

8,591,938
8,592,480

Antares Pharma, Inc. v. Medac Pharma, Inc., 14-0270 (D. Del.)

Feb. 28, 2014

Hon. Sue L. Robinson

OtrexupTM (methotrexate injection)

8,480,631
6,565,553

Bausch & Lomb Inc. v. Sandoz Inc., 14-1325
(D.N.J.)

Mar. 2, 2014

Hon. Noel L. Hillman

Bepreve® (bepotastine besilate 1.5% solution/drops)

6,780,877

Novartis Pharma. Corp. v. Pharmaceutics Int’l, Inc., 14-1347 (D.N.J.)

Mar. 3, 2014

Hon. Susan D. Wigenton

Zometa® (zoledronic acid injection)

8,324,189

Janssen Products, L.P. v. Lupin Ltd., 14-1370
(D.N.J.)

Mar. 4, 2014

Hon. William H. Walls

Prezista® (darunavir tablets)

8,518,987

Roxane Labs., Inc. v. Camber Pharma., Inc., 14-0232
(S.D. Ohio)

Mar. 4, 2014

Hon. Gregory L. Frost

calcium acetate capsules

8,563,032

Sanofi v. Alkem Labs. Ltd., 14-0292 (D. Del.)

Mar. 6, 2014

Hon. Richard G. Andrews

Multaq® (dronedarone tablets)

7,323,493
8,318,800
8,410,167
8,602,215

Sanofi v. First Time US Generics LLC, 14-0293
(D. Del.)

Mar. 6, 2014

Hon. Richard G. Andrews

Multaq® (dronedarone tablets)

8,318,800
8,410,167
8,602,215

Sanofi v. Sun Pharma Global FZE, 14-0294 (D. Del.)

Mar. 6, 2014

Hon. Richard G. Andrews

Multaq® (dronedarone tablets)

7,323,493
8,318,800
8,410,167
8,602,215

Allergan, Inc. v. Actavis PLC, 14-0188 (E.D. Tex.)

Mar. 6, 2014

Hon. Rodney Gilstrap

Restasis® (cyclosporine ophthalmic emulsion 0.05%)

8,629,111

Medac Pharma., Inc. v. Antares Pharma., Inc., 14-1498 (D.N.J.)

Mar. 7, 2014

Hon. Jerome B. Simandle

OtrexupTM (methotrexate injection)

8,664,231

Eli Lilly and Co. v. Accord Healthcare, Inc. USA, 14-0389 (S.D. Ind.)

Mar. 12, 2014

Hon. Sarah Evans Barker

Effient® (prasugrel hydrochloride tablets)

5,288,726
8,404,703
8,569,325

Eli Lilly and Co. v. Accord Healthcare, Inc. USA, 14-1643 (D.N.J.)

Mar. 13, 2014

Hon. Claire C. Cecchi

Effient® (prasugrel hydrochloride tablets)

5,288,726
8,404,703
8,569,325

Cephalon, Inc. v. Sun Pharma Global FZE, 14-0333 (D. Del.)

Mar. 14, 2014

Hon. Gregory M. Sleet

Treanda® (bendamustine hydrochloride)

8,609,863

Cephalon, Inc. v. Dr. Reddy’s Labs., Ltd., 14-0334 (D. Del.)

Mar. 14, 2014

Hon. Gregory M. Sleet

Treanda® (bendamustine hydrochloride)

8,609,863

Cephalon, Inc. v. Emcure Pharma Ltd., 14-0335
(D. Del.)

Mar. 14, 2014

Hon. Gregory M. Sleet

Treanda® (bendamustine hydrochloride)

8,445,524

Sanofi v. Sun Pharma Global FZE, 14-1844 (N.D. Ill.)

Mar. 14, 2014

Hon. Ruben Castillo

Multaq® (dronedarone tablets)

7,323,493
8,318,800
8,410,167
8,602,215

Astellas US LLC v. Emcure Pharma. USA, Inc., 14-1665 (D.N.J.)

Mar. 14, 2014

Hon. Stanley R. Chesler

Adenoscan® (adenosine injection)

5,731,296

Otsuka Pharma. Co., Ltd. v. Amneal Pharma., LLC, 14-1688 (D.N.J.)

Mar. 14, 2013

Hon. Mary L. Cooper

Abilify® (aripiprazole oral solution)

7,053,092

Pfizer Inc. v. Torrent Pharma. Ltd., 14-1704 (D.N.J.)

Mar. 17, 2014

Hon. Mary L. Cooper

Viagra® (sildenafil citrate tablets)

6,469,012

Cephalon, Inc. v. Emcure Pharma Ltd., 14-1705
(D. Del.)

Mar. 17, 2014

Hon. Peter G. Sheridan

Treanda® (bendamustine hydrochloride)

8,445,524

Pfizer Inc. v. Torrent Pharma. Ltd., 14-1831 (S.D.N.Y.)

Mar. 17, 2014

Hon. Paul A. Engelmayer

Viagra® (sildenafil citrate tablets)

6,469,012

Bristol-Myers Squibb Co. v. Apotex, Inc., 14-0351
(D. Del.)

Mar. 19, 2014

Hon. Richard G. Andrews

Baraclude® (entecavir tablets)

5,206,244

Sanofi v. Alkem Labs. Ltd., 14-1957 (N.D. Ill.)

Mar. 19, 2014

Hon. Ruben Castillo

Multaq® (dronedarone tablets)

7,323,493
8,318,800
8,410,167
8,602,215

UCB, Inc. v. Corepharma, L.L.C., 14-1788 (D.N.J.)

Mar. 20, 2014

Hon. Faith S. Hochberg

Metadate CD® (methylphenidate hydrochloride capsules)

6,344,215

ViiV Healthcare UK Ltd. v. Lupin Ltd., 14-0369 (D. Del.)

Mar. 21, 2014

Hon. Richard G. Andrews

Epzicom® (abacavir sulfate / lamivudine tablets)

6,417,191
6,294,540

Bayer Pharma AG v. Watson Labs., Inc., 14-1804 (D.N.J.)

Mar. 21, 2014

Hon. Jose L. Linares

Staxyn® (vardenafil hydrochloride tablets)

8,613,950

Novartis Pharma. Corp. v. Gland Pharma Ltd., 14-1841 (D.N.J.)

Mar. 21, 2014

Hon. Susan D. Wigenton

Reclast® (zoledronic acid injection)

8,052,987

Bausch & Lomb, Inc. v. Akorn, Inc., 14-1866 (D.N.J.)

Mar. 24, 2014

Hon. Noel L. Hillman

Bepreve® (bepotastine besilate ophthalmic solution)

6,780,877

Novartis Pharma. Corp. v. Dr. Reddy’s Labs., Ltd., 14-0387 (D. Del.)

Mar. 26, 2014

Hon. Leonard P. Stark

Gleevec® (imatinib mesylate capsules)

RE43,932

Mallinckrodt LLC v. Amneal Pharma. LLC, 14-0389
(D. Del.)

Mar. 27, 2014

Hon. Richard G. Andrews

Pennsaid® (diclofenac sodium topical solution)

8,217,078
8,546,450
8,618,164

Bausch & Lomb, Inc. v. Micro Labs. Ltd., 14-1974 (D.N.J.)

Mar. 28, 2014

Hon. Noel L. Hillman

Bepreve® (bepotastine besilate ophthalmic solution)

6,780,877

Bausch & Lomb, Inc. v. Apotex, Inc., 14-1975 (D.N.J.)

Mar. 28, 2014

Hon. Noel L. Hillman

Bepreve® (bepotastine besilate ophthalmic solution)

6,780,877

Otsuka Pharma. Co., Ltd. v. Wockhardt Bio AG, 14-1979 (D.N.J.)

Mar. 28, 2014

Hon. Jerome B. Simandle

Abilify® (aripiprazole tablets)

8,017,615
8,580,796

Supernus Pharma. Inc. v. Actavis, Inc., 14-1981 (D.N.J.)

Mar. 28, 2014

Hon. Renee M. Bumb

Oxtellar XR™ (oxcarbazepine extended-release tablets)

8,617,600

The articles on our Website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice.